| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DurCalciPhos | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | acd082d1-c167-4350-b3f2-6b8384d25140 | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | b3c84c93-1aa2-493f-8645-e20f4586eb30 | 2 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion | 12 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | CMPK SOLUTION | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | Anticoagulant Citrate Dextrose Solution, USP (ACD), Solution A | 1 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | Oral7 ® | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE MONOHYDRATE | 4 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | KETO-PLEX FORTE | 3 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | Oxytocin 20 USP Units Added to 5% Dextrose/Lactated Ringer's 1,000 mL Bag | 3 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | Drug Facts | 1 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | Drug Facts | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 70% Dextrose Injection, USP | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | CMPK2 | 3 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 93033b8f-5f57-4b95-b556-fc0fd1ec5b87 | 3 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | ebe41590-2f62-4140-92b0-2a5e03b541fe | 3 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | ZOSYN ® (Piperacillin and Tazobactam Injection) in Galaxy ® Containers (PL 2040 Plastic) | 11 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | a89254e4-5905-4374-9972-3c8b2b317af9 | 2 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 52370e0e-e6ba-43cd-879c-589f429452c7 | 2 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 74d27255-d95b-4913-bc10-1201e5c805c3 | 1 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | Triple Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1) | 2 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DRUG FACTS | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 41006552-baf9-4a0d-84bc-cb9a7139911b | 4 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DRUG FACTS | 1 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DRUG FACTS | 2 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DRUG FACTS | 2 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 7bb20ea0-ea59-414e-9cb4-2a102127b77d | 2 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | ee96df1f-5499-4679-9d7a-fed4953141f6 | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | f5302b40-62a9-4f86-a369-abb4b418c1b0 | 4 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | aa30134e-8e02-4618-b44b-36eaeffd77dd | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | c1a66389-4006-468e-9799-07bae53de02a | 3 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 4018639a-987c-43c9-9aab-fe1d09fb0e50 | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 68bf06bd-2fe3-4da0-9c54-91c807715da4 | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 046ae4d9-6299-42b4-affb-3dec78984c2f | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 51b99671-28a6-4b15-918b-85c48588fb16 | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 6a34a467-02b3-481b-8704-fd5bfcbcdc1a | 6 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 1643ed50-7c75-4df9-bffb-f0353c97e3c2 | 3 |
| Dextrose Monohydrate | INACTIVE INGREDIENT | Temporary Fibromyalgia Pain and Discomfort Relief | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 73a7ba2e-f3d9-4b15-808c-33acdc6a70ec | 4 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | CP2D/AS-3 Blood Collection and Sampling System | 3 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | Dextrose Solution 50% | 1 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | TREXIMET ® (sumatriptan and naproxen sodium) Tablets | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | Sterile Cord Blood Collection Unit Code 791-08 | 3 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | c0dd68b3-20af-464d-b3ba-34eb886df6ae | 1 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 24fe5d5e-6128-4da9-af4c-ac2d99a36822 | 2 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | 6d1199d2-4a7d-4e6c-9785-2688888377bc | 1 |
| Dextrose Monohydrate | INACTIVE INGREDIENT | e6731360-a309-1652-6c43-5235076c18a4 | 2 |
| Dextrose monohydrate | ACTIVE INGREDIENT | e049b79d-d174-440e-88fa-a602ce666900 | 1 |
| Dextrose Hydrous | ACTIVE INGREDIENT | 5% Dextrose and Electrolyte No. 75 Injection (Multiple Electrolytes and Dextrose Injection, Type 3, USP) in VIAFLEX Plastic Container | 1 |
| Dextrose hydrous | ACTIVE INGREDIENT | Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) in Viaflex® Plastic Container | 1 |
| Dextrose hydrous | INACTIVE INGREDIENT | CEFIZOX ® (ceftizoxime injection) IN GALAXY ® PLASTIC CONTAINER (PL2040) | 1 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | NP THYROID 30 (LEVOTHYROXINE, LIOTHYRONINE) TABLET [BRYANT RANCH PREPACK] | 1000 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 23 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | ZOSYN (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN IN GALAXY CONTAINERS (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 19 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | ZOSYN (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN PHARMACY BULK PACKAGE (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN IN GALAXY CONTAINERS (TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM) INJECTION, SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 19 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFEPIME HYDROCHLORIDE AND DEXTROSE (CEFEPIME HYDROCHLORIDE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 18 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | HEPARIN SODIUM IN DEXTROSE (HEPARIN SODIUM AND DEXTROSE) INJECTION [B. BRAUN MEDICAL INC.] | 18 |
| Dextrose Monohydrate | INACTIVE INGREDIENT | TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM) TABLET, FILM COATED [PERNIX THERAPEUTICS] | 18 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 17 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | NITROGLYCERIN IN DEXTROSE (NITROGLYCERIN) INJECTION, SOLUTION [HOSPIRA, INC.] | 17 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | TREXIMET (SUMATRIPTAN AND NAPROXEN SODIUM) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | 16 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | ISOLYTE P IN DEXTROSE (DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 15 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | NORMOSOL-M AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFTRIAXONE (CEFTRIAXONE SODIUM) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 14 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DIANEAL PD-2 WITH DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE) INJECTION, SOLUTION DIANEAL LOW CALCIUM WITH DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 14 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LACTATED RINGERS AND DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION LACTATED RINGERS (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | MAGNESIUM SULFATE IN DEXTROSE (MAGNESIUM SULFATE HEPTAHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE (POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | RINGERS (SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE) INJECTION, SOLUTION RINGERS AND DEXTROSE (SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | CPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 13 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 13 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | ERWINAZE (ASPARAGINASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [JAZZ PHARMACEUTICALS, INC.] | 13 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LIDOCAINE HYDROCHLORIDE AND DEXTROSE (LIDOCAINE HYDROCHLORIDE AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LMD IN DEXTROSE (DEXTRAN 40) INJECTION, SOLUTION LMD IN SODIUM CHLORIDE (DEXTRAN 40) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
| dextrose monohydrate | INACTIVE INGREDIENT | CIPROFLOXACIN INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 12 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DOPAMINE HYDROCHLORIDE AND DEXTROSE (DOPAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | FLUCONAZOLE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LIDOCAINE HYDROCHLORIDE AND DEXTROSE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | POTASSIUM CHLORIDE IN DEXTROSE (DEXTROSE MONOHYDRATE AND POTASSIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | VITAMIN K1 (PHYTONADIONE) INJECTION, EMULSION [HOSPIRA, INC.] | 12 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CIPROFLOXACIN INJECTION, SOLUTION CIPROFLOXACIN INJECTION, SOLUTION, CONCENTRATE [CLARIS LIFESCIENCES INC.] | 11 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE (DOBUTAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DOPAMINE HYDROCHLORIDE AND DEXTROSE (DOPAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | IBUPROFEN TABLET [GRANULES INDIA LIMITED] | 11 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | IONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | IONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 11 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LIDOCAINE HYDROCHLORIDE AND DEXTROSE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 11 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFEPIME INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 10 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 10 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | FLUCONAZOLE INJECTION [CLARIS LIFESCIENCES INC.] | 10 |
| Dextrose monohydrate | ACTIVE INGREDIENT | PRISMASOL BGK0/2.5 (CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, AND SODIUM BICARBONATE) SOLUTION PRISMASOL BGK4/2.5 (CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE) SOLUTION PRISMASOL BGK2/3.5 (CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE) SOLUTION PRISMASOL BGK2/0 (MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE) SOLUTION PRISMASOL B22GK4/0 (MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE) SOLUTION PRISMASOL B | 10 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | VETERINARY DEXTROSE AND SODIUM CHLORIDE (DEXTROSE AND SODIUM CHLORIDE) INJECTION, SOLUTION [ABBOTT LABORATORIES] | 10 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFAZOLIN (CEFAZOLIN SODIUM) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 9 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CEFAZOLIN SODIUM SOLUTION [B. BRAUN MEDICAL INC.] | 9 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | CIPROFLOXACIN INJECTION, SOLUTION [HOSPIRA, INC.] | 9 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | CPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 9 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 9 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | FLUCONAZOLE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 9 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | NASAL DECONGESTANT PE (PHENYLEPHRINE HCL) TABLET, FILM COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED] | 9 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | THEOPHYLLINE IN DEXTROSE (THEOPHYLLINE ANHYDROUS AND DEXTROSE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 9 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 |
| Dextrose monohydrate | ACTIVE INGREDIENT | CAL DEX CMPK INJECTION, SOLUTION [ASPEN VETERINARY] | 8 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 8 |
| Dextrose Monohydrate | ACTIVE INGREDIENT | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 8 |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | DEXTROSE IN LACTATED RINGERS (DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 8 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE (DOBUTAMINE HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 8 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | NAFCILLIN INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | OXACILLIN INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 |
pubchem.ncbi.nlm.nih.gov/compound/22814120
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1299920
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61717
precision.fda.gov/uniisearch/srs/unii/LX22YL083G